Boris Guiu

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Étienne Garin, Lambros Tselikas, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 604 citations

Medicine, Oncology, Radiation Oncology +17

Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study

Emmanuel Mitry, Boris Guiu, Simona Cosconea et al. · Gut · 2010 · 377 citations

Medicine, Biostatistics, Oncology +17

Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial

Naïk Vietti Violi, Rafael Durán, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 293 citations

Medicine, Oncology, Hepatology +10

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma

Julien Edeline, Yann Touchefeu, Boris Guiu et al. · JAMA Oncology · 2019 · 293 citations · Full text

Medicine, Oncology, Radiation Oncology +15